The CHK1 inhibitor MU380 significantly increases the sensitivity of human docetaxel-resistant prostate cancer cells to gemcitabine through the induction of mitotic catastrophe

S Drápela; P Khirsariya; Wytske van Weerden; R Fedr; T Suchánková; D Búzová; J ?ervený; A Hampl; M Puhr; WR Watson; Z Culig; L Krej?í; K Paruch; K Sou?ek

doi:10.1002/1878-0261.12756

The CHK1 inhibitor MU380 significantly increases the sensitivity of human docetaxel-resistant prostate cancer cells to gemcitabine through the induction of mitotic catastrophe

S Drápela, P Khirsariya, Wytske van Weerden, R Fedr, T Suchánková, D Búzová, J ?ervený, A Hampl, M Puhr, WR Watson, Z Culig, L Krej?í, K Paruch, K Sou?ek

Urology

Research output: Contribution to journal › Article › Academic

4 Downloads (Pure)

Original language	English
Pages (from-to)	2487-2503
Number of pages	17
Journal	Molecular Oncology
Volume	14
Issue number	10
DOIs	https://doi.org/10.1002/1878-0261.12756
Publication status	Published - 2020

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1002/1878-0261.12756

Repub_129027_O-A.pdfFinal published version, 4.81 MB

http://hdl.handle.net/1765/129027

Cite this

Drápela, S., Khirsariya, P., van Weerden, W., Fedr, R., Suchánková, T., Búzová, D., ?ervený, J., Hampl, A., Puhr, M., Watson, WR., Culig, Z., Krej?í, L., Paruch, K., & Sou?ek, K. (2020). The CHK1 inhibitor MU380 significantly increases the sensitivity of human docetaxel-resistant prostate cancer cells to gemcitabine through the induction of mitotic catastrophe. Molecular Oncology, 14(10), 2487-2503. https://doi.org/10.1002/1878-0261.12756

@article{2875a407f0524c46b30585e0e311908d,

title = "The CHK1 inhibitor MU380 significantly increases the sensitivity of human docetaxel-resistant prostate cancer cells to gemcitabine through the induction of mitotic catastrophe",

author = "S Dr{\'a}pela and P Khirsariya and {van Weerden}, Wytske and R Fedr and T Such{\'a}nkov{\'a} and D B{\'u}zov{\'a} and J ?erven{\'y} and A Hampl and M Puhr and WR Watson and Z Culig and L Krej?{\'i} and K Paruch and K Sou?ek",

year = "2020",

doi = "10.1002/1878-0261.12756",

language = "English",

volume = "14",

pages = "2487--2503",

journal = "Molecular Oncology",

issn = "1574-7891",

publisher = "John Wiley & Sons Ltd.",

number = "10",

}

Drápela, S, Khirsariya, P, van Weerden, W, Fedr, R, Suchánková, T, Búzová, D, ?ervený, J, Hampl, A, Puhr, M, Watson, WR, Culig, Z, Krej?í, L, Paruch, K & Sou?ek, K 2020, 'The CHK1 inhibitor MU380 significantly increases the sensitivity of human docetaxel-resistant prostate cancer cells to gemcitabine through the induction of mitotic catastrophe', Molecular Oncology, vol. 14, no. 10, pp. 2487-2503. https://doi.org/10.1002/1878-0261.12756

TY - JOUR

T1 - The CHK1 inhibitor MU380 significantly increases the sensitivity of human docetaxel-resistant prostate cancer cells to gemcitabine through the induction of mitotic catastrophe

AU - Drápela, S

AU - Khirsariya, P

AU - van Weerden, Wytske

AU - Fedr, R

AU - Suchánková, T

AU - Búzová, D

AU - ?ervený, J

AU - Hampl, A

AU - Puhr, M

AU - Watson, WR

AU - Culig, Z

AU - Krej?í, L

AU - Paruch, K

AU - Sou?ek, K

PY - 2020

Y1 - 2020

U2 - 10.1002/1878-0261.12756

DO - 10.1002/1878-0261.12756

M3 - Article

VL - 14

SP - 2487

EP - 2503

JO - Molecular Oncology

JF - Molecular Oncology

SN - 1574-7891

IS - 10

ER -